Defect in the lymphoid compartment might account for CD8+-mediated effects in the pathophysiology of pure red cell aplasia

Clinical Immunology

Volumn 108, Issue 3, 2003, Pages 248-256

  Rameshwar, Pranela ^a   Ramkissoon, Shakti H ^a   Sundararajan, Selvaraj ^a   Gascón, Pedro ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Cytotoxic; Erythroid; Erythropoietin; Interleukin 2; Lymphoid; Pure red cell aplasia; T cells

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; BURST FORMING UNIT E; CASE REPORT; CELL ADHESION; CELL LINEAGE; CELL MATURATION; CELLULAR DISTRIBUTION; COLONY FORMING UNIT E; ERYTHROCYTE APLASIA; ERYTHROID PRECURSOR CELL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MALE; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0141788718     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00139-6     Document Type: Article

References (37)

1. Dessypris E.N. The biology of pure red cell aplasia. Seminars in Hematol. 28:1991;275-284.
2. Fisch P., Handgretiner R., Schaefer H.-.E. Pure Red Cell Aplasia. Br. J. Hematol. 111:2000;1010-1022.
3. Beard M.E., Krantz S.B., Johnson S.A.N., Bateman C.J.T., Whitehouse J.M. Pure Red Cell Aplasia. Quarterly J. Med. 187:1978;339-348.
4. Croisille L., Tchernia G., Casadevall N. Autoimmune disorders of erythropoiesis. Current Opin. Hematol. 8:2001;68-73.
5. Fisch J.W., Moris A., Rammensee H.G., Handgretinger R. Inhibitory MHC class I receptors on T cells in tumour immunity and autoimmunity. Immunol. Today. 21:2000;187-191.
6. Kurtzman G., Frickhofen N., Kimball J., Jenkins D.W., Nienhuis A.W., Young N.S. Pure red cell aplasia of 10 years duration due to persistent parvovirus B-19 infection and its cure with immunoglobulin therapy. New Engl. J. Med. 321:1989;519-523.
7. Casadevall N., Nataf J., Viron B., Kolta A., Kiladjian J.J., Martin-Dupont P., Michaud P., Papo T., Ugo V., Teyssandier I., Varet B., Mayeux P. Pure red-cell aplasia and antierithropoietin antibodies in patients treated with recombinant erythropoietin. New Engl. J. Med. 346:2002;469-475.
8. Takahashi M., Nikkuni K., Tanaka I., Furukawa T., Moriyama Y., Shibata A., Satoh S., Kuwabara T., Maruyama Y., Matsunaga Y. Serum erythropoietic inhibitors in patients with pure red cell aplasia. Ann. Hematol. 63:1991;9-14.
9. Tsujimura H., Sakai C., Takagi T. Pure red cell aplasia complicated by angioimmunoblastic T-cell lymphoma humoral factor plays a main role in the inhibition of erythropoiesis from CD34+ progenitor cells . Am. J. Hematol. 62:1999;259-262.
10. Handgretinger R., Geiselhart A., Moris A., Grau R., Teuffel O., Bethge W., Kanz L., Fisch P. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. New Engl. J. Med. 340:1999;278-284.
11. Levinson A., Hoxie J., Kornstein M., Zembryki D., Matthews D., Schreiber A. Absence of the OKT4 epitope on blood T cells and thymus cells in a patient with thymoma, hypogammaglobulinemia, and red blood cell aplasia. J. Allergy Clin. Immunol. 76:1985;433-439.
12. Peschle A., Marmont A.M., Marone G., Genovese A., Sasso G.F., Condorelli M. Pure red cell aplasia studies on an IgG serum inhibitor neutralizing erythropoietin . Br. J. Haematol. 30:1975;411-417.
13. Go R.S., Tefferi A., Phyliky R.L. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood. 98:2001;483-485.
14. Charles R.J., Sabo K.M., Kidd P.G., Abkowitz J.L. The pathophysiology of pure red cell anamia implications for therapy . Blood. 87:1996;4831-4838.
15. Aggio M.C., Zunini C. Reversible pure red cell aplasia in pregnancy. New Engl. J. Med. 299:1977;777-780.
16. Lehman G., Alcoff J. Reversible pure red cell hypoplasia in pregnancy. J. Am. Med. Assoc. 247:1982;1170-1173.
17. Miyoshi I., Hikita T., Koi B., Kimura I. Reversible pure red cell aplasia in pregnancy. New Engl. J. Med. 297:1977;221-224.
18. Strobel P., Helmreich M., Menioudakis G., Lewin S.R., Rudiger T., Bauer A., Hoffacker V., Gold R., Nix W., Schalke B., Elert O., Semik M., Muller-Hermelink H.K., Marx A. Paraneoplastic myasthenia gravis correlates with generation of mature maive CD4+ T cells in thymomas. Blood. 100:2002;159-166.
19. Fröland S.S., Wisloff F., Stavem P. Abnormal lymphocyte populations in pure red cell aplasia. Scand. J. Haematol. 17:1976;241-250.
20. null mice. Exp. Hematol. 30:2002;488-494.
21. Gascon P., Zoumbos N.C., Young N.S. Immunologic abnormalities in patients receiving multiple transfusions. Ann. Int. Med. 100:1984;173-176.
22. Rameshwar P., Denny T., Stein D., Gascón P. Adhesion of monocytes from patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for IL-1 and TGF-β J. Immunol. 153:1994;2819-2830.
23. Rameshwar P., Zhu G., Donnelly R.J., Qian J., Ge H., Goldstein K.R., Denny T.N., Gascón P. The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P An understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell . J. Neuroimmunol. 121:2001;22-31.
24. Rameshwar P., Gascon P., Oh H.S., Denny T., Zhu G., Ganea D. Vasoactive Intestinal Peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor. Exp. Hematol. 30:2002;1001-1009.
25. Rameshwar P., Smith I., Ende N., Batarseh H.E., Ponzio N.M. Endogenous hematopoietic reconstitution induced by human umbilical cord blood cells in immunocompromised mice implications for adoptive therapy . Exp. Hematol. 27:1999;176-185.
26. Rameshwar P., Gascon P., Ganea D. Immunoregulatory effects of neuropeptides. Stimulation of interleukin-2 production by substance P. J. Neuroimmunol. 37:1992;65-74.
27. Dessypris E.N., Krantz S.B. Effect of pure erythropoietin on DNA synthesis by human marrow day 15 erythroid burst forming units in short-term liquid culture. Br. J. Haematol. 56:1984;295-306.
28. Nijhof W., Wierenga P.K., Sahr K., Beru N., Goldwasser E. Induction of globin mRNA transcription by erythropoietin in differentiating erythroid precursor cells. Exp. Hematol. 15:1987;779-784.
29. Ko S., Dahlke M.H., Lauth O., Jager M.D., Deiwick A., Dinkel A., Tsui T.-.Y., Wonigeit K., Schlitt H.J. Bone marrow aplasia induced by passenger leukocytes from heart allografts. Exp. Hematol. 29:2001;339-344.
30. Milnes J.P., Goorney B.P., Walington T.B. Pure red cell aplasia and thymoma associated with high levels of the suppressor/cytotoxic T lymphocyte subset. Br. Med. J. 289:1984;1333-1338.
31. King A.G., Kondo M., Scherer D.C., Weissman I.L. Lineage infidelity in myeloid cells with TCR gene rearrangement a latent developmental potential of pro T cells revealed by ectopic cytokine receptor signalling . Proc. Natl Acad. Sci. USA. 99:2002;4508-4513.
32. Masuda M., Arai Y., Okamura T., Mizoguchi H. Pure red cell aplasia with thymoma evidence of T-cell clonal disorder . Am. J. Hematol. 54:1997;324-328.
33. Matsutani T., Yoshioka T., Tsuruta Y., Shimamoto T., Ohyashiki J.H., Suzuki R., Ohyashiki K. Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia. Leuk. Res. 27:2003;305-312.
34. Granjo E., Lima M., Correia T., Lisboa C., Magalhaes C., Cunha N., Teixeira M.A., Queiros M.L., Candeias J., Matutes E. Cd8+/vβ5.1+ large granular lymphocyte leukemia associated with autoimmune cytopenias, rheumatoid arthritis and vascular mammary skin lesions successful response to 2-deoxycoformycin . Hematol. Oncol. 20:2002;87-93.
35. Mangan K., Volkin R., Winkelstein A. Autoreactive erythroid progenitor-T suppressor cells in the pure red cell aplasia associated with thymoma and panhypogammaglobulinemia. Am. J. Hematol. 23:1986;167-173.
36. Levitt S.E.G., Burdach L.J. Receptor-specific inhibition of bone marrow erythropoiesis by recombinant DNA-derived interleukin-2. Blood. 69:1987;1368-1375.
37. Zoumbos N., Gascon P., Trost S., Djeu J., Young N. Circulating activated suppressor T lymphocyte in aplastic anemia. New Engl. J. Med. 312:1985;257-265.